
Full doses of blood thinners can benefit patients hospitalized with COVID-19, but the severity of their illness matters, researchers say. The new global analysis found that hospitalized patients with moderate COVID-19 may benefit from the drugs’ clot-preventing powers, but patients with illness so severe it requires admission to an intensive care unit may not. “SARS-CoV-2… read on > read on >